Janet Kidd Net Worth

Janet Kidd biography

Janet Louise Kidd serves as General Counsel, Company Secretary of the Company. Before joining Oxford Immunotec, Ms. Kidd served as Associate General Counsel at The Wellcome Trust and prior to that at Aegerion Pharmaceuticals for three years, from 2018 to 2019 as Deputy General Counsel and from 2016 to 2018 as VP, Legal EMEA, where she oversaw all legal and compliance activities in EMEA. Prior to that Ms. Kidd was a Director, Business Conduct EMEA at Gilead Sciences and held senior in-house legal roles at Baxter Healthcare from 2010 to 2015. From 2007 to 2010 Ms. Kidd worked at Covington & Burlington LLP advising life science clients on corporate and commercial transactions, with special expertise on global collaborations and cross-border deals. Before her career in law, Ms. Kidd spent nearly 15 years as a research and development scientist. Ms. Kidd earned her Bachelor’s degree in Chemistry from the University of Hertfordshire.

How old is Janet Kidd?

Janet Kidd is 50, she's been the General Counsel and Company Secretary of Oxford Immunotec Global PLC since 2019. There are 8 older and 2 younger executives at Oxford Immunotec Global PLC. The oldest executive at Oxford Immunotec Global PLC is Richard Sandberg, 77, who is the Independent Director.

What's Janet Kidd's mailing address?

Janet's mailing address filed with the SEC is C/O OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RZ.

Insiders trading at Oxford Immunotec Global PLC

Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith, and Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.

What does Oxford Immunotec Global PLC do?

Oxford Immunotec Global PLC executives and stock owners

Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include:

• Peter Wrighton-Smith,
  Chief Executive Officer, Director
• Matthew McLaughlin,
  Chief Financial Officer
• Richard Sandberg,
  Independent Director
• Patrick Balthrop,
  Independent Chairman of the Board
• Herman Rosenman,
  Independent Director
• James Tobin,
  Independent Director
• Patricia Randall,
  Independent Director
• Andrew Walton,
  Independent Director
• Mark Klausner,
  Independent Director
• Ronald Andrews,
  Independent Director
• Janet Kidd,
  General Counsel, Company Secretary
• Herm Rosenman,
  
• Richard M. Altieri,
  Chief Financial Officer
• Peter Edwardson,
  Chief Operations Officer
• Stephen L Spotts,
  Director
• Jeff R. Schroeder,
  Chief Commercial Officer
• Richard Wenstrup,
  Chief Medical Officer
• Stefan C Linn,
  Chief Operating Officer
• Elizabeth M Keiley,
  VP & General Counsel
• Lifesciences I, L.P.Clarus ...,
  
• Leaf Ventures Ii, L.P.New L...,